OSTEOCHONDRODYSPLASIA

OSTEOCHONDRODYSPLASIA was reported 24 times

OSTEOCHONDRODYSPLASIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Oxytocic [EPC] 1 0.0003
1 Purine Antimetabolite [EPC] 7 0.0001
2 Phosphodiesterase 5 Inhibitor [EPC] 7 0.0001
3 Prostacycline Vasodilator [EPC] 7 0.0001
4 Tetracycline-class Drug [EPC] 3 0.0000
5 Alkaloid [EPC] 1 0.0000
6 Endothelin Receptor Antagonist [EPC] 7 0.0000
7 Factor Xa Inhibitor [EPC] 7 0.0000
8 Mood Stabilizer [EPC] 4 0.0000
9 Anti-epileptic Agent [EPC] 4 0.0000
10 Azole Antifungal [EPC] 2 0.0000
11 Anti-IgE [EPC] 1 0.0000
12 Prostaglandin Analog [EPC] 1 0.0000
13 Vitamin D [EPC] 3 0.0000
14 Antirheumatic Agent [EPC] 1 0.0000
15 Vitamin B12 [EPC] 3 0.0000
16 Vitamin C [EPC] 3 0.0000
17 Corticosteroid [EPC] 9 0.0000
18 HMG-CoA Reductase Inhibitor [EPC] 2 0.0000
19 Proton Pump Inhibitor [EPC] 2 0.0000
20 Benzodiazepine [EPC] 2 0.0000
21 Nonsteroidal Anti-inflammatory Drug [EPC] 3 0.0000
22 GLP-1 Receptor Agonist [EPC] 1 0.0000
23 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000